Grey Wolf Animal Health Corp. (WOLF.V)
| Previous Close | 0.7200 |
| Open | 0.8100 |
| Bid | 0.7200 x N/A |
| Ask | 0.8300 x N/A |
| Day's Range | 0.8100 - 0.8100 |
| 52 Week Range | 0.6000 - 1.0000 |
| Volume | |
| Avg. Volume | 12,142 |
| Market Cap | 25.136M |
| Beta (5Y Monthly) | 0.42 |
| PE Ratio (TTM) | 40.50 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- CNW Group
GREY WOLF ANIMAL HEALTH REPORTS FOURTH QUARTER AND YEAR END 2023 FINANCIAL RESULTS
Grey Wolf Animal Health Corp. (TSXV: WOLF) ("Grey Wolf" or the "Company"), a Canadian diversified animal health company, today announced financial results for the fourth quarter and year ended December 31, 2023.
- CNW Group
GREY WOLF ANIMAL HEALTH TO PRESENT AT THE 2024 BLOOM BURTON & CO. HEALTHCARE INVESTOR CONFERENCE
Grey Wolf Animal Health Corp. (TSXV: WOLF) ("Grey Wolf" or the "Company"), a Canadian diversified animal health company, today announced that Angela Cechetto, CEO, is scheduled to present a corporate update at the 2024 Bloom Burton & Co. Healthcare Investor Conference on Wednesday April 17, 2024 at 3:00pm ET at the Metro Toronto Convention Centre in Toronto.
- CNW Group
GREY WOLF ANIMAL HEALTH REPORTS THIRD QUARTER AND NINE MONTHS ENDED SEPTEMBER 30, 2023 FINANCIAL RESULTS
Grey Wolf Animal Health Corp. (TSXV: WOLF) ("Grey Wolf" or the "Company"), a Canadian diversified animal health company, today announced financial results for the quarter and nine months ended September 30, 2023.
